EGFRTKIs相关论文
Survivals in Advanced EGFR-Mutant NSCLC Patients Treated with First-Generation EGFR TKIs followed by
...
EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise its effectiveness in lung ca
Objective Lung cancer is the most frequent cause of cancer-associated deaths worldwide,and NSCLC(non-small cell lung can......
目的：吉非替尼(gefitinib,iressa)、厄洛替尼(erlotinib,tarceva)为代表的表皮生长因子酪氨酸激酶抑制剂(epidermal growth factor ......
目的：探讨EGFR TKIs在晚期肺腺癌靶向治疗中的疗效及预后。方法：选取我院近期接受EGFR-TKIs治疗的晚期肺腺癌患者24例。所有患者均经......
目的:现如今靶向治疗已成为晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)治疗中必不可少的重要手段,表皮生长因子受体酪氨......
